Literature DB >> 3706523

Leucine and isoleucine activate skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo.

R P Aftring, K P Block, M G Buse.   

Abstract

The response of rat skeletal muscle branched-chain alpha-keto acid dehydrogenase to administration of branched-chain amino acids in vivo was determined using a soluble preparation of the enzyme. After detergent extraction of the complex in the presence of kinase and phosphatase inhibitors, initial in vivo activity was typically 1 nmol X min-1 X g muscle-1, with 0.1 mM alpha-[1-14C]ketoisocaproate as substrate. Total activity of the dephosphorylated complex, measured after preincubation with 15 mM Mg2+, typically reached a maximum of 29 nmol X min-1 X g-1. Thus in overnight-fasted rats the complex was 2-3% active. Initial activity increased three- to fivefold after leucine or isoleucine (at higher concentrations) but not valine administration in vivo. After intravenous leucine injection (0.25 mmol/kg) initial muscle enzyme activity increased rapidly and subsequently decreased, paralleling plasma leucine concentrations, while plasma valine and isoleucine decreased. In conclusion, muscle branched-chain alpha-keto acid dehydrogenase complex is rapidly activated when circulating leucine is increased to concentrations that may occur after meals. During hyperleucinemia accelerated valine and isoleucine degradation by muscle may account for the observed "antagonism" among the branched-chain amino acids.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706523     DOI: 10.1152/ajpendo.1986.250.5.E599

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Leucine or carbohydrate supplementation reduces AMPK and eEF2 phosphorylation and extends postprandial muscle protein synthesis in rats.

Authors:  Gabriel J Wilson; Donald K Layman; Christopher J Moulton; Layne E Norton; Tracy G Anthony; Christopher G Proud; S Indu Rupassara; Peter J Garlick
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-13       Impact factor: 4.310

2.  Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase.

Authors:  M D Nawabi; K P Block; M C Chakrabarti; M G Buse
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Decreased plasma isoleucine concentrations after upper gastrointestinal haemorrhage in humans.

Authors:  C H Dejong; W J Meijerink; C L van Berlo; N E Deutz; P B Soeters
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Effects of insulin on ovine fetal leucine kinetics and protein metabolism.

Authors:  J R Milley
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

5.  Mechanisms of activation of muscle branched-chain alpha-keto acid dehydrogenase during exercise in man.

Authors:  G van Hall; D A MacLean; B Saltin; A J Wagenmakers
Journal:  J Physiol       Date:  1996-08-01       Impact factor: 5.182

Review 6.  Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.

Authors:  Sean H Adams
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

7.  Contribution of leucine to oxidative metabolism of the rat medullary thick ascending limb.

Authors:  M M Trinh-Trang-Tan; O Levillain; L Bankir
Journal:  Pflugers Arch       Date:  1988-06       Impact factor: 3.657

8.  Impaired oxidation of branched-chain amino acids in the medial thalamus of thiamine-deficient rats.

Authors:  Darren Navarro; Claudia Zwingmann; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2008-09-05       Impact factor: 3.584

9.  Modulation of rat skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo. Effects of dietary protein and meal consumption.

Authors:  K P Block; R P Aftring; W B Mehard; M G Buse
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

10.  Side effects of amino acid supplements.

Authors:  M Holeček
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.